Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 127 Pages
Report ld: 3498560
Request Sample
Customized Report
COVID-19 Rapid Antibody Test Kits Market Size(US$)

CAGR 2025-2031
-21.7%
Market Size,2031
USD 2,327
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
North American market for COVID-19 Rapid Antibody Test Kits was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for COVID-19 Rapid Antibody Test Kits was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for COVID-19 Rapid Antibody Test Kits was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of COVID-19 Rapid Antibody Test Kits include RayBiotech Life, Aurora Biomed, SD Biosensor, Abingdon Health, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics, TestLine Clinical Diagnostics, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Rapid Antibody Test Kits, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of COVID-19 Rapid Antibody Test Kits by region & country, by Type, and by Application.
The COVID-19 Rapid Antibody Test Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Rapid Antibody Test Kits.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of COVID-19 Rapid Antibody Test Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of COVID-19 Rapid Antibody Test Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of COVID-19 Rapid Antibody Test Kits in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 COVID-19 Rapid Antibody Test Kits Product Introduction
1.2 Global COVID-19 Rapid Antibody Test Kits Market Size Forecast
1.2.1 Global COVID-19 Rapid Antibody Test Kits Sales Value (2020-2031)
1.2.2 Global COVID-19 Rapid Antibody Test Kits Sales Volume (2020-2031)
1.2.3 Global COVID-19 Rapid Antibody Test Kits Sales Price (2020-2031)
1.3 COVID-19 Rapid Antibody Test Kits Market Trends & Drivers
1.3.1 COVID-19 Rapid Antibody Test Kits Industry Trends
1.3.2 COVID-19 Rapid Antibody Test Kits Market Drivers & Opportunity
1.3.3 COVID-19 Rapid Antibody Test Kits Market Challenges
1.3.4 COVID-19 Rapid Antibody Test Kits Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global COVID-19 Rapid Antibody Test Kits Players Revenue Ranking (2024)
2.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Company (2020-2025)
2.3 Global COVID-19 Rapid Antibody Test Kits Players Sales Volume Ranking (2024)
2.4 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Company Players (2020-2025)
2.5 Global COVID-19 Rapid Antibody Test Kits Average Price by Company (2020-2025)
2.6 Key Manufacturers COVID-19 Rapid Antibody Test Kits Manufacturing Base and Headquarters
2.7 Key Manufacturers COVID-19 Rapid Antibody Test Kits Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of COVID-19 Rapid Antibody Test Kits
2.9 COVID-19 Rapid Antibody Test Kits Market Competitive Analysis
2.9.1 COVID-19 Rapid Antibody Test Kits Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by COVID-19 Rapid Antibody Test Kits Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Rapid Antibody Test Kits as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IgG Test
3.1.2 IgM Test
3.1.3 Others
3.2 Global COVID-19 Rapid Antibody Test Kits Sales Value by Type
3.2.1 Global COVID-19 Rapid Antibody Test Kits Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global COVID-19 Rapid Antibody Test Kits Sales Value, by Type (2020-2031)
3.2.3 Global COVID-19 Rapid Antibody Test Kits Sales Value, by Type (%) (2020-2031)
3.3 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Type
3.3.1 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global COVID-19 Rapid Antibody Test Kits Sales Volume, by Type (2020-2031)
3.3.3 Global COVID-19 Rapid Antibody Test Kits Sales Volume, by Type (%) (2020-2031)
3.4 Global COVID-19 Rapid Antibody Test Kits Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Company
4.1.3 School
4.1.4 Home
4.1.5 Others
4.2 Global COVID-19 Rapid Antibody Test Kits Sales Value by Application
4.2.1 Global COVID-19 Rapid Antibody Test Kits Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global COVID-19 Rapid Antibody Test Kits Sales Value, by Application (2020-2031)
4.2.3 Global COVID-19 Rapid Antibody Test Kits Sales Value, by Application (%) (2020-2031)
4.3 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Application
4.3.1 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global COVID-19 Rapid Antibody Test Kits Sales Volume, by Application (2020-2031)
4.3.3 Global COVID-19 Rapid Antibody Test Kits Sales Volume, by Application (%) (2020-2031)
4.4 Global COVID-19 Rapid Antibody Test Kits Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global COVID-19 Rapid Antibody Test Kits Sales Value by Region
5.1.1 Global COVID-19 Rapid Antibody Test Kits Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global COVID-19 Rapid Antibody Test Kits Sales Value by Region (2020-2025)
5.1.3 Global COVID-19 Rapid Antibody Test Kits Sales Value by Region (2026-2031)
5.1.4 Global COVID-19 Rapid Antibody Test Kits Sales Value by Region (%), (2020-2031)
5.2 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Region
5.2.1 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Region (2020-2025)
5.2.3 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Region (2026-2031)
5.2.4 Global COVID-19 Rapid Antibody Test Kits Sales Volume by Region (%), (2020-2031)
5.3 Global COVID-19 Rapid Antibody Test Kits Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
5.4.2 North America COVID-19 Rapid Antibody Test Kits Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
5.5.2 Europe COVID-19 Rapid Antibody Test Kits Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
5.6.2 Asia Pacific COVID-19 Rapid Antibody Test Kits Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
5.7.2 South America COVID-19 Rapid Antibody Test Kits Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
5.8.2 Middle East & Africa COVID-19 Rapid Antibody Test Kits Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions COVID-19 Rapid Antibody Test Kits Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions COVID-19 Rapid Antibody Test Kits Sales Value
6.2.1 Key Countries/Regions COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.2.2 Key Countries/Regions COVID-19 Rapid Antibody Test Kits Sales Volume, 2020-2031
6.3 United States
6.3.1 United States COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.3.2 United States COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.3.3 United States COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.4.2 Europe COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.5.2 China COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.5.3 China COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.6.2 Japan COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.7.2 South Korea COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.8.2 Southeast Asia COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India COVID-19 Rapid Antibody Test Kits Sales Value, 2020-2031
6.9.2 India COVID-19 Rapid Antibody Test Kits Sales Value by Type (%), 2024 VS 2031
6.9.3 India COVID-19 Rapid Antibody Test Kits Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 RayBiotech Life
7.1.1 RayBiotech Life Company Information
7.1.2 RayBiotech Life Introduction and Business Overview
7.1.3 RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 RayBiotech Life COVID-19 Rapid Antibody Test Kits Product Offerings
7.1.5 RayBiotech Life Recent Development
7.2 Aurora Biomed
7.2.1 Aurora Biomed Company Information
7.2.2 Aurora Biomed Introduction and Business Overview
7.2.3 Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Aurora Biomed COVID-19 Rapid Antibody Test Kits Product Offerings
7.2.5 Aurora Biomed Recent Development
7.3 SD Biosensor
7.3.1 SD Biosensor Company Information
7.3.2 SD Biosensor Introduction and Business Overview
7.3.3 SD Biosensor COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 SD Biosensor COVID-19 Rapid Antibody Test Kits Product Offerings
7.3.5 SD Biosensor Recent Development
7.4 Abingdon Health
7.4.1 Abingdon Health Company Information
7.4.2 Abingdon Health Introduction and Business Overview
7.4.3 Abingdon Health COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Abingdon Health COVID-19 Rapid Antibody Test Kits Product Offerings
7.4.5 Abingdon Health Recent Development
7.5 INSTI
7.5.1 INSTI Company Information
7.5.2 INSTI Introduction and Business Overview
7.5.3 INSTI COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 INSTI COVID-19 Rapid Antibody Test Kits Product Offerings
7.5.5 INSTI Recent Development
7.6 CTK Biotech
7.6.1 CTK Biotech Company Information
7.6.2 CTK Biotech Introduction and Business Overview
7.6.3 CTK Biotech COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 CTK Biotech COVID-19 Rapid Antibody Test Kits Product Offerings
7.6.5 CTK Biotech Recent Development
7.7 SBL Testing Technologies
7.7.1 SBL Testing Technologies Company Information
7.7.2 SBL Testing Technologies Introduction and Business Overview
7.7.3 SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Product Offerings
7.7.5 SBL Testing Technologies Recent Development
7.8 Biopanda
7.8.1 Biopanda Company Information
7.8.2 Biopanda Introduction and Business Overview
7.8.3 Biopanda COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Biopanda COVID-19 Rapid Antibody Test Kits Product Offerings
7.8.5 Biopanda Recent Development
7.9 Roche Diagnostics
7.9.1 Roche Diagnostics Company Information
7.9.2 Roche Diagnostics Introduction and Business Overview
7.9.3 Roche Diagnostics COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Roche Diagnostics COVID-19 Rapid Antibody Test Kits Product Offerings
7.9.5 Roche Diagnostics Recent Development
7.10 TestLine Clinical Diagnostics
7.10.1 TestLine Clinical Diagnostics Company Information
7.10.2 TestLine Clinical Diagnostics Introduction and Business Overview
7.10.3 TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Product Offerings
7.10.5 TestLine Clinical Diagnostics Recent Development
7.11 Assay Genie
7.11.1 Assay Genie Company Information
7.11.2 Assay Genie Introduction and Business Overview
7.11.3 Assay Genie COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Assay Genie COVID-19 Rapid Antibody Test Kits Product Offerings
7.11.5 Assay Genie Recent Development
7.12 Nadal-test
7.12.1 Nadal-test Company Information
7.12.2 Nadal-test Introduction and Business Overview
7.12.3 Nadal-test COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Nadal-test COVID-19 Rapid Antibody Test Kits Product Offerings
7.12.5 Nadal-test Recent Development
7.13 Panodyne
7.13.1 Panodyne Company Information
7.13.2 Panodyne Introduction and Business Overview
7.13.3 Panodyne COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Panodyne COVID-19 Rapid Antibody Test Kits Product Offerings
7.13.5 Panodyne Recent Development
7.14 Luminex
7.14.1 Luminex Company Information
7.14.2 Luminex Introduction and Business Overview
7.14.3 Luminex COVID-19 Rapid Antibody Test Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Luminex COVID-19 Rapid Antibody Test Kits Product Offerings
7.14.5 Luminex Recent Development
8 Industry Chain Analysis
8.1 COVID-19 Rapid Antibody Test Kits Industrial Chain
8.2 COVID-19 Rapid Antibody Test Kits Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 COVID-19 Rapid Antibody Test Kits Sales Model
8.5.2 Sales Channel
8.5.3 COVID-19 Rapid Antibody Test Kits Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 10100 million in 2025 and is projected to reach US$ 1873 million, growing at a CAGR of -21.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
The global COVID-19 Rapid Antibody Test Kits market was valued at US$ 10100 million in 2025 and is anticipated to reach US$ 1873 million by 2032, at a CAGR of -21.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
The global COVID-19 Rapid Antibody Test Kits market size was US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
The global COVID-19 Rapid Antibody Test Kits market is projected to grow from US$ 12550 million in 2024 to US$ 2327 million by 2031, at a CAGR of -21.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 155
USD 4900.00
(Single User License)
The global market for COVID-19 Rapid Antibody Test Kits was valued at US$ 12550 million in the year 2024 and is projected to reach a revised size of US$ 2327 million by 2031, growing at a CAGR of -21.7% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 10100 million in 2025 and is projected to reach US$ 1873 million, growing at a CAGR of -21.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
The global COVID-19 Rapid Antibody Test Kits market was valued at US$ 10100 million in 2025 and is anticipated to reach US$ 1873 million by 2032, at a CAGR of -21.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 126
The global COVID-19 Rapid Antibody Test Kits market size was US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
The global COVID-19 Rapid Antibody Test Kits market is projected to grow from US$ 12550 million in 2024 to US$ 2327 million by 2031, at a CAGR of -21.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 155
The global market for COVID-19 Rapid Antibody Test Kits was valued at US$ 12550 million in the year 2024 and is projected to reach a revised size of US$ 2327 million by 2031, growing at a CAGR of -21.7% during the forecast period.
Published: 2025-01-13
Pages: 90
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
Published: 2024-01-17
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now